Artal Group’s Sigilon Therapeutics, Inc. Common Stock SGTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-21,231
| Closed | -$139K | – | 138 |
|
|
2022
Q3 | $139K | Hold |
21,231
| – | – | 0.01% | 130 |
|
|
2022
Q2 | $229K | Hold |
21,231
| – | – | 0.01% | 129 |
|
|
2022
Q1 | $406K | Hold |
21,231
| – | – | 0.02% | 131 |
|
|
2021
Q4 | $762K | Hold |
21,231
| – | – | 0.02% | 136 |
|
|
2021
Q3 | $1.56M | Hold |
21,231
| – | – | 0.03% | 132 |
|
|
2021
Q2 | $2.96M | Hold |
21,231
| – | – | 0.06% | 123 |
|
|
2021
Q1 | $6.17M | Hold |
21,231
| – | – | 0.11% | 106 |
|
|
2020
Q4 | $13.3M | Buy |
+21,231
| New | +$13.3M | 0.28% | 75 |
|